https://scholars.lib.ntu.edu.tw/handle/123456789/470193
標題: | Differential expression of glucocorticoid receptor in carcinomas of the human digestive system | 作者: | HUANG-CHUN LIEN YEN-SHEN LU CHIA-TUNG SHUN Yao Y.-T. Chang W.-C. ANN-LII CHENG |
公開日期: | 2008 | 卷: | 52 | 期: | 3 | 起(迄)頁: | 314-324 | 來源出版物: | Histopathology | 摘要: | Aims: To investigate the in situ expression profile of glucocorticoid receptor (GR) in normal and carcinomatous tissues of the human digestive system. Methods and results: Specimens from 306 carcinomas of the human digestive tract were assayed for the expression of GR by immunohistochemistry. GR expression was strong in oesophageal squamous epithelia, pancreatic islet cells and hepatocytes, but generally weak or negative in non-squamous epithelia. Consistently, GR expression was found in a high percentage of oesophageal squamous cell carcinomas (SCC) (98.1%) and hepatocellular carcinomas (HCC) (92.9%), but rarely in gastric adenocarcinomas (7.4%) and not at all in colorectal adenocarcinomas (0%). Dexamethasone (DEX) was found to confer chemoresistance in oesophageal SCC and HCC cells, suggesting that GR expression may be biologically important in some GR-expressing carcinomas. Conclusions: Distribution of GR expression is markedly diverse among tissues of the human digestive system. The general lack of GR in adenocarcinomas contrasts with the high percentage of SCCs and HCCs expressing GR, and, along with the generation of chemoresistance by DEX, warrants prospective study of the effects of steroids on these cancers. ? 2008 The Authors. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-38849205380&doi=10.1111%2fj.1365-2559.2007.02953.x&partnerID=40&md5=1e4fe63cd697dfa55a7b318b84ad2300 https://scholars.lib.ntu.edu.tw/handle/123456789/470193 |
ISSN: | 0309-0167 | DOI: | 10.1111/j.1365-2559.2007.02953.x | SDG/關鍵字: | cisplatin; dexamethasone; doxorubicin; fluorouracil; glucocorticoid receptor; paclitaxel; article; colorectal carcinoma; controlled study; digestive system cancer; esophageal squamous cell carcinoma; esophagus; gene expression; human; human cell; human tissue; immunohistochemistry; liver cell; liver cell carcinoma; pancreas islet cell; priority journal; squamous epithelium; stomach adenocarcinoma; Adenocarcinoma; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Common Bile Duct Neoplasms; Dexamethasone; Digestive System Neoplasms; DNA, Neoplasm; Drug Resistance, Neoplasm; Humans; Immunoenzyme Techniques; Receptors, Glucocorticoid; Sequence Analysis, DNA; Survival Rate; Tumor Markers, Biological |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。